PLX Financial Facts
GENERAL AND ADMINISTRATIVE EXPENSES: -1.53MCOST OF REVENUES: -220K
See Full Income Statement
Total liabilities: 78.18M
Total assets: 60.83M
See Full Balance Sheet
Protalix Biotherapeutics, Inc. (PLX) Earnings
|
Expand Research on PLX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -23.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/11/22 | Q222 | N/A | -$0.05 | N/A | N/A | $15.1M | N/A | N/A | N/A | ||
| 5/16/22 |  |
Q122 | -$0.05 | N/A | N/A | $16.1M | $15.5M | N/A |  | | Details |
3/31/22  |
|
Q421 | N/A | -$0.11 | N/A | N/A | $7.79M | N/A | N/A | N/A | |
| 11/15/21 | |
Q321 | -$0.09 | $0.00 | -$0.09 | $12.05M | $6.9M | N/A | | | Details |
| 8/16/21 | |
Q221 | -$0.25 | -$0.08 | -$0.17 | $6.43M | $8.3M | N/A | | | Details |
| 5/14/21 | |
Q121 | -$0.14 | -$0.17 | +$0.03 | $11.32M | $10.95M | N/A | | | Details |
| 3/30/21 |
|
Q420 | $0.00 | -$0.08 | +$0.08 | N/A | $11.99M | N/A | | | Details |
| 10/29/20 | |
Q320 | $0.00 | N/A | N/A | $10.8M | $10.08M | N/A | | | Details |
